These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37903944)

  • 21. Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions.
    Caballero ML; Krantz MS; Quirce S; Phillips EJ; Stone CA
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):2968-2982. PubMed ID: 33737254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why are Excipients Important to Neonates?
    Turner MA; Shah U
    Curr Pharm Des; 2015; 21(39):5680-7. PubMed ID: 26323411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory Notes on Impact of Excipients on Drug Products and the Maillard Reaction.
    Chowdhury DK; Sarker H; Schwartz P
    AAPS PharmSciTech; 2018 Feb; 19(2):965-969. PubMed ID: 28948567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of the ocular safety of inactive excipients following sub-tenon injection in rabbits.
    Younis HS; Shawer M; Palacio K; Gukasyan HJ; Stevens GJ; Evering W
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):206-16. PubMed ID: 18345993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous anaphylactoid reaction to polyoxyethylene hydrogenated castor oil in dogs.
    Sugiyama Y; Kawarai S; Ansai S; Bist P; Abraham SN; Maruo T
    Vet Dermatol; 2024 Jun; 35(3):263-272. PubMed ID: 38111025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of suspected adverse reactions to veterinary medicinal products reported in South Africa (March 2002 - February 2003).
    Naidoo V
    J S Afr Vet Assoc; 2003 Dec; 74(4):137-40. PubMed ID: 15038429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
    Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
    Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are excipients really inert ingredients? A review of adverse reactions to excipients in oral dermatologic medications in Canada.
    Noiles K; Vender R
    J Cutan Med Surg; 2010; 14(3):105-14. PubMed ID: 20487670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaphylaxis to Excipients in Current Clinical Practice: Evaluation and Management.
    Bruusgaard-Mouritsen MA; Nasser S; Garvey LH; Krantz MS; Stone CA
    Immunol Allergy Clin North Am; 2022 May; 42(2):239-267. PubMed ID: 35469617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of fatty acid composition after saponification of common oil pharmaceutical excipients by supercritical fluid-evaporative light scattering method and its application in oil identification].
    Wang ZY; Shi HW; Ma CY; Liu WY; Chen L; Liu Z; Yuan YZ; Zhang M; Tang S
    Se Pu; 2024 Jun; 42(6):581-589. PubMed ID: 38845519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentially harmful excipients in neonatal medicines: a pan-European observational study.
    Nellis G; Metsvaht T; Varendi H; Toompere K; Lass J; Mesek I; Nunn AJ; Turner MA; Lutsar I;
    Arch Dis Child; 2015 Jul; 100(7):694-9. PubMed ID: 25854872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon.
    Mouiche MMM; Njingou BZN; Moffo F; Mpouam SE; Feussom JMK; Awah-Ndukum J
    BMC Vet Res; 2019 Aug; 15(1):301. PubMed ID: 31426790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Challenges in Drug Allergy: the Resurgence of Excipients.
    Venturini Díaz M; Vidal Oribe I; D'Elia Torrence D; Hernández Alfonso P; Alarcón Gallardo E
    Curr Treat Options Allergy; 2022; 9(3):273-291. PubMed ID: 35910462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ¹³C solid-state NMR analysis of the most common pharmaceutical excipients used in solid drug formulations, Part I: Chemical shifts assignment.
    Pisklak DM; Zielińska-Pisklak MA; Szeleszczuk Ł; Wawer I
    J Pharm Biomed Anal; 2016 Apr; 122():81-9. PubMed ID: 26845204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Veterinary pharmacovigilance. Part 4. Adverse reactions in humans to veterinary medicinal products.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):185-201. PubMed ID: 15842307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solubilizing excipients in oral and injectable formulations.
    Strickley RG
    Pharm Res; 2004 Feb; 21(2):201-30. PubMed ID: 15032302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
    Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
    Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive review on pharmaceutical excipients.
    Pockle RD; Masareddy RS; Patil AS; Patil PD
    Ther Deliv; 2023 Jul; 14(7):443-458. PubMed ID: 37464784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of common pharmaceutical excipients on the gut microbiota.
    Subramaniam S; Kamath S; Ariaee A; Prestidge C; Joyce P
    Expert Opin Drug Deliv; 2023; 20(10):1297-1314. PubMed ID: 37307224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Presence of excipients in pharmaceutical products in 3 sources of therapeutic information].
    Altimiras J; Nieto-Hernández T; Buitrago F
    Aten Primaria; 1996 Sep; 18(4):190-3. PubMed ID: 8963000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.